Home/Filings/4/0001127602-23-014569
4//SEC Filing

Williams David Michael 4

Accession 0001127602-23-014569

CIK 0000310158other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 6:22 PM ET

Size

5.9 KB

Accession

0001127602-23-014569

Insider Transaction Report

Form 4
Period: 2023-05-02
Williams David Michael
EVP,Chief Info&Digital Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-02+19,36419,364 total
    Exercise: $117.89From: 2024-05-02Exp: 2033-05-01Common Stock (19,364 underlying)
Holdings
  • Common Stock

    11,058.96
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001820958

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:22 PM ET
Size
5.9 KB